Gangliosidosis generalizada tipo 1
Hernández García, Iván; Seiglie Díaz, Frances; Campos Hernández, Derbis; Marrón Portarles, Lourdes; Díaz González, Jorge Luís; Carmona Padrón, Orlando.
Rev. cuba. pediatr
; 86(1): 103-107, abr.-jun. 2014.
Artigo em Espanhol | LILACS | ID: lil-709199
Documentos relacionados
Natural history of GM1 gangliosidosis-Retrospective cohort study of 61 French patients from 1998 to 2019.
Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients.
Synthesis of a New ß-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis.
An autopsy case of G<sub>M1</sub> gangliosidosis type II in a patient who survived a long duration with artificial respiratory support.
Intracerebroventricular enzyme replacement therapy with ß-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.
Gene therapy approaches for GM1 gangliosidosis: Focus on animal and cellular studies.
Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis.
Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis.
Disentangling molecular and clinical stratification patterns in beta-galactosidase deficiency.
[Genetic and clinical analysis of a novel GLB1 gene variant in a Chinese patient with GM1-gangliosidosis].